Literature DB >> 31667147

Primary central nervous system lymphoma: is whole-body CT and FDG PET/CT for initial imaging reasonable?

Hana Malikova1.   

Abstract

Entities:  

Year:  2019        PMID： 31667147      PMCID： PMC6785507          DOI： 10.21037/qims.2019.09.06

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN： 2223-4306


× No keyword cloud information.
  12 in total

1.  Primary Central Nervous System Lymphoma: Diagnostic Yield of Whole-Body CT and FDG PET/CT for Initial Systemic Imaging.

Authors:  Chong Hyun Suh; Ho Sung Kim; Ji Eun Park; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Radiology       Date:  2019-06-25       Impact factor: 11.105

2.  Spontaneous remission of primary central nervous system lymphoma: report of 3 cases and discussion of pathophysiology.

Authors:  M Al-Yamany; A Lozano; S Nag; N Laperriere; M Bernstein
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

3.  Complications of MRI-guided stereotactic biopsy of brain lymphoma.

Authors:  Hana Malikova; Roman Liscak; Iva Latnerova; Khumar Guseynova; Martin Syrucek; Robert Pytlik
Journal:  Neuro Endocrinol Lett       Date:  2014       Impact factor: 0.765

4.  The utility of body FDG PET in staging primary central nervous system lymphoma.

Authors:  Nimish A Mohile; Lisa M Deangelis; Lauren E Abrey
Journal:  Neuro Oncol       Date:  2008-02-20       Impact factor: 12.300

5.  The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.

Authors:  Brian Patrick O'Neill; Paul A Decker; Christina Tieu; James R Cerhan
Journal:  Am J Hematol       Date:  2013-09-12       Impact factor: 10.047

6.  Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion.

Authors:  A J Ferreri; M Reni; M C Zoldan; M R Terreni; E Villa
Journal:  Cancer       Date:  1996-03-01       Impact factor: 6.860

7.  EBV and HIV-Related Lymphoma.

Authors:  Michele Bibas; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

8.  Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?

Authors:  H Malikova; E Koubska; J Weichet; J Klener; A Rulseh; R Liscak; Z Vojtech
Journal:  Cancer Imaging       Date:  2016-11-29       Impact factor: 3.909

9.  Trends in primary central nervous system lymphoma incidence and survival in the U.S.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Caroline Besson; Christina A Clarke; Lindsay M Morton; Leticia Nogueira; Karen Pawlish; Elizabeth L Yanik; Gita Suneja; Eric A Engels
Journal:  Br J Haematol       Date:  2016-03-28       Impact factor: 8.615

10.  Secondary central nervous system lymphoma: spectrum of morphological MRI appearances.

Authors:  Hana Malikova; Miroslava Burghardtova; Eva Koubska; Vaclav Mandys; Tomas Kozak; Jiri Weichet
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-12       Impact factor: 2.570
View more
  2 in total

1.  Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water-fat separation Dixon.

Authors:  Xiaodong Ji; Wenyang Huang; Huazheng Dong; Zhiwei Shen; Meizhu Zheng; Dehui Zou; Wen Shen; Shuang Xia
Journal:  Quant Imaging Med Surg       Date:  2021-02

2.  Primary peripheral T-cell central nervous system lymphoma.

Authors:  Cylaina E Bird; Jeffrey I Traylor; Jenna Thomas; James P Caruso; Benjamin Kafka; Flavia Rosado; Kyle M Blackburn; Kimmo J Hatanpaa; Kalil G Abdullah
Journal:  Surg Neurol Int       Date:  2021-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.